참고문헌
- Aoki, T. 1988. Drug-resistant plasmids from fish pathogens. Microbiol. Sci. Rev. 5: 219-223.
- Bachmann, B. J. 1990. Linkage map of Escherichia coli K-12, edition 8. Microbiol. Rev. 54: 130-197.
- Bebear, C. M., O. Grau, A. Charron, H. Renaudin, D. Gruson, and C. Bebear. 2000. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin. Antimicrob. Agents Chemother. 44: 2719-2727. https://doi.org/10.1128/AAC.44.10.2719-2727.2000
- Beckmann, L., M. Muller, P. Luber, C. Schrader, E. Bartelt, and G. Klein. 2004. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing. J. Appl. Microbiol. 96: 1040-1047. https://doi.org/10.1111/j.1365-2672.2004.02242.x
- Belland, R., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14: 371-380. https://doi.org/10.1111/j.1365-2958.1994.tb01297.x
- Blanche, R., B. Cameron, F. X. Bernard, L. Maton, B. Manse, L. Ferrero, et al. 1996. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob. Agents Chemother. 40: 2714-2720.
- Bjorkman, J., I. Nagaev, and O. G. Berg. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287: 1479-1482. https://doi.org/10.1126/science.287.5457.1479
- Cecile, M. B., A. Charron, J. M. Bove, C. Bebear, and J. Renaudin. 1998. Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis. Antimicrob. Agents Chemother. 42: 2024-2031.
- Chen, C. R., M. Malik, M. Snyder, and K. Drlica. 1996. DNA gyrase and topoisomerase IV on the bacterial chromosome: Quinolone-induced DNA cleavage. J. Mol. Biol. 258: 627-637. https://doi.org/10.1006/jmbi.1996.0274
- Colman, S. D., P. C. Hu, and K. F. Bott. 1990. Mycoplasma pneumoniae DNA gyrase genes. Mol. Microbiol. 4: 1129-1134. https://doi.org/10.1111/j.1365-2958.1990.tb00687.x
- Deborah, J. E., L. Randall, D. T. Gray, A. Buckley, M. J. Woodward, A. P. White, and L. J. V. Piddock. 2004. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob. Agents Chemother. 48: 4012-4015. https://doi.org/10.1128/AAC.48.10.4012-4015.2004
- Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Kawada, T. Ezaki, and I. Saito. 1996. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 40: 2437-2438.
- Drlica, K. and X. Zhao. 1997. Gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61: 377-392.
- Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39: 1554-1558. https://doi.org/10.1128/AAC.39.7.1554
- Gensberg, K., Y. F. Jin, and L. J. Piddock. 1995. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella Typhimurium. FEMS Microbiol. Lett. 132: 57-60. https://doi.org/10.1111/j.1574-6968.1995.tb07810.x
- Georgiou, M., R. Munoz, F. Roman, R. Canton, R. Gomez-Lus, J. Campos, and A. G. D. L. Campa. 1996. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob. Agents Chemother. 40: 1741-1744.
- Gonzalez, I., M. Georgiou, F. Alcaide, D. Balas, J. Linares, and A. G. Campa. 1998. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci. Antimicrob. Agents Chemother. 42: 2792-2798.
- Heisig, P. 1993. High-level fluoroquinolone resistance in a Salmonella Typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32: 367-378. https://doi.org/10.1093/jac/32.3.367
- Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40: 879-885.
- Hopewell, R., M. Oram, R. Briesewitz, and L. M. Fisher. 1990. DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: Close homology among gyrase proteins and implications for 4-quinolone action and resistance. J. Bacteriol. 172: 3481-3484.
- Horowitz, D. S. and J. C. Wang. 1987. Mapping the active site tyrosine of Escherichia coli DNA gyrase. J. Biol. Chem. 262: 5339-5344.
- Jalal, S. and B. Wretlind. 1998. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb. Drug Res. 4: 257-261. https://doi.org/10.1089/mdr.1998.4.257
- Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Hiraga, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63: 393-404. https://doi.org/10.1016/0092-8674(90)90172-B
- Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92: 11801-11805. https://doi.org/10.1073/pnas.92.25.11801
- Kim, S. H., O. Y. Lim, S. H. Kim, J. Y. Kim, Y. H. Kang, and B. K. Lee. 2003. Pulsed-field gel electrophoresis and mutation typing of gyrA gene of quinolone-resistant Salmonella enterica serovar Paratyphi A isolated from outbreak and sporadic cases, 1998-2002, Korea. J. Microbiol. Biotechnol. 13: 155-158.
- Lee, K. E., M. Y. Lee, J. Y. Lim, J. H. Jung, Y. H. Park, and Y. H. Lee. 2008. Contamination of chicken meat with Salmonella enterica serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility. J. Microbiol. Biotechnol. 18: 1853-1857.
- Lindback, E., M. Rahman, S. Jalal, and B. Wretlind. 2002. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 110: 651-657. https://doi.org/10.1034/j.1600-0463.2002.1100909.x
- Ling, J. M., E. W. Chan, A. W. Lam, and A. F. Cheng. 2003. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob. Agents Chemother. 47: 3567-3573. https://doi.org/10.1128/AAC.47.11.3567-3573.2003
- Margerrison, E., R. Hopewell, and L. M. Fisher. 1992. Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J. Bacteriol. 174: 1596-1603.
- Mclver, C. J., T. R. Hogan, P. A. White, and J. W. Tapsall. 2004. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations. Pathology. 36: 166-169. https://doi.org/10.1080/00313020410001672019
- Moriya, S., N. Ogasawara, and H. Yoshikawa. 1985. Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region. Nucleic Acids Res. 13: 2251-2265. https://doi.org/10.1093/nar/13.7.2251
- Nakamura, S. 1997. Mechanisms of quinolone resistance. J. Infect. Chemother. 3: 128-138. https://doi.org/10.1007/BF02491502
- Nakano, M., T. Deguchi, T. Kawamura, M. Yasuda, M. Kimura, Y. Okano, and Y. Kawada. 1997. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41: 2289-2291.
- Ng, E. Y., M. Trucksis, and D. C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: Relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40: 1881-1888.
- Oram, M. and M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35: 387-389. https://doi.org/10.1128/AAC.35.2.387
- Ouabdesselam, S., D. C. Hooper, J. Tankovic, and C. J. Soussy. 1995. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob. Agents Chemother. 39: 1667-1670. https://doi.org/10.1128/AAC.39.8.1667
- Pan, X. and L. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: Role in fluoroquinolone resistance. J. Bacteriol. 178: 4060-4069.
- Shin, S. B., M. H. Yoo, J. B. Jeong, Y. M. Kim, J. K. Chung, M. D. Huh, J. L. Komisar, and H. D. Jeong. 2005. Molecular cloning of the gyrA gene and characterization of its mutation in clinical isolates of quinolone-resistant Edwardsiella tarda. Dis. Aquat. Org. 67: 259-266. https://doi.org/10.3354/dao067259
- Springer, A. L. and M. B. Schmid. 1993. Molecular characterization of the Salmonella Typhimurium parE gene. Nucleic Acids Res. 21: 1805-1809. https://doi.org/10.1093/nar/21.8.1805
- Stein, D. C., R. J. Danaher, and T. M. Cook. 1991. Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 35: 622-626. https://doi.org/10.1128/AAC.35.4.622
- Stock, I. and B. Wiedemann. 2001. Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae. Antimicrob. Agents Chemother. 45: 2245-2255. https://doi.org/10.1128/AAC.45.8.2245-2255.2001
- Trees, D. L., A. L. Sandul, W. L. Whittington, and J. S. Knapp. 1998. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 42: 2103-2105.
- Yamagishi, J., H. Yoshida, M. Yamayoshi, and S. Nakamura. 1986. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol. Gen. Genet. 204: 367-373. https://doi.org/10.1007/BF00331012
피인용 문헌
- DNA Gyrase and Topoisomerase IV Mutations and their effect on Quinolones Resistant Proteus mirabilis among UTIs Patients vol.36, pp.6, 2020, https://doi.org/10.12669/pjms.36.6.2207